Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00676598 · ClinicalTrials.gov registry record

A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac Arrest

A clinical trial of Cardiac Arrest, sponsored by Advocate Hospital System.

Completed
Registry status
70
Enrollment target
1
Study location

NCT00676598 is a study of Cardiac Arrest that has completed, run by Advocate Hospital System. The registered enrollment target is 70 participants, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00676598, a study of Cardiac Arrest, has completed, sponsored by Advocate Hospital System.

COMPLETED
Registry status
70 participants
Enrollment target
1
Study location

Study Summary

Therapeutic hypothermia has been shown to improve survival and neurologic outcome in patients resuscitated after ventricular fibrillation arrest. Few studies have examined whether therapeutic hypothermia is effective outside the research setting, or with other presenting rhythms. Our institution, a large community teaching hospital, instituted a therapeutic hypothermia protocol in November 2006 for all resuscitated cardiac arrest patients. The investigators seek to determine the mortality rate of our protocol and compare our complication rates with those of previously published studies.

Conditions Studied

Study Locations (1)

Illinois

  • Adcovate Christ Hospital - Oak Lawn

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2007-01
Est. Completion 2010-12

Sponsor

Advocate Hospital System

4 total trials

What the Registry Record Tells You About NCT00676598

The ClinicalTrials.gov registry entry for NCT00676598 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (95% lower). The listed sponsor is Advocate Hospital System, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiac Arrest appearing as the primary indexed condition, and to 0 interventions.

NCT00676598 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00676598 about?

NCT00676598 is a clinical study titled "A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac Arrest". Therapeutic hypothermia has been shown to improve survival and neurologic outcome in patients resuscitated after ventricular fibrillation arrest. Few studies have examined whether therapeutic hypothermia is effective outside the research setting, or with other presenting rhythms. Our institution, ...

What is the current status of trial NCT00676598?

This trial is currently completed. The enrollment target is 70 participants. The study started on 2007-01. Estimated completion is 2010-12.

What conditions does trial NCT00676598 study?

This clinical trial studies the following conditions: Cardiac Arrest.

Who is sponsoring clinical trial NCT00676598?

This trial is sponsored by Advocate Hospital System, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00676598 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Arrest

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.